N/A N=135 Diagnostics in the Leg Ulcer Pathway
Venous Leg Ulcer
Primary: Primary Care Practitioners and the Management of Venous Leg Ulcers. — 50; 34; 45 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=100 A Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)
Multiple Sclerosis
Primary: Annualized Relapse Rate (ARR) — 0.02 relapses per year
Phase 1 N=108 A Study to Assess the Total Systemic Exposure Bioequivalence of of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA Propellant
Chronic Obstructive Pulmonary Disease
Primary: Area Under Plasma Concentration-time Curve From Zero to Infinity (AUCinf) — 4047; 4112; 4012; 85.62 hour*picogram/milliliter (h*pg/mL)
Phase 2 N=100 Cold-stored Platelet Early Intervention in TBI
Traumatic Brain Injury
Primary: Study Feasibility — 50; 50 Participants
N/A N=100 Efficacy of an Antibacterial Toothpaste and Patients' Satisfaction
Caries · Gingivitis
Primary: Bacterial Count of Streptococcus Mutans (S. Mutans) — 4.261; 4.277 log CFU/ml
N/A N=16 Investigation of the Effects of Dietary Fibres on the Gut Microbiome in a Transgenerational Cohort
Gut Health
Primary: Stool Short-chain Fatty Acids Production Following Each Intervention Between Mothers and Daughters — 50; 26; 41.7; 47.8 umol/g
N/A N=110 Mindfulness Program for Adolescents With 22q11DS
22Q11 Deletion Syndrome
Primary: Change From Baseline in Adolescents' Coping Skills — 3.10; 2.68; 3.18; 2.79 units on a scale — p=0.04
Phase 2 N=25 MEN1703 (SEL24) in Participants With Acute Myeloid Leukemia
Acute Myeloid Leukemia
Primary: Part 1 and Part 2: Number of Participants Experiencing Treatment-emergent Adverse Events — 2; 3; 3; 6 Participants
Phase 2 N=52 Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer.
Metastatic Prostatic Adenocarcinoma
Primary: PSA Response at 10 Months — 15 Participants
N/A N=30 DBT for Metastatic Lung Cancer
Lung Cancer Metastatic
Primary: Feasibility as Measured by Study Accrual — 31 Participants
N/A N=681 Evaluation of the Safer Bars Prevention Program for Sexual Assault
Sexual Assault Precursor Behavior
Primary: Number of Participants Who Reported Always Intervening Behavior at 6 Months — 207; 239 Participants
Phase 4 N=90 Effects of Intrauterine Flushing With Human Chorionic Gonadotropin on ICSI Outcome
Female Infertility
Primary: Serum Level of TNF-alfa,IL-10, for All Participants in Three Study Group at Day of Ova Pickup Compared to That at Day of Embryo Transfer — 43.56; 41.59; 40.94; 30.33 pg/ml
N/A N=60 Perianastomotic Drain After Gastrectomy (DRAG)
Gastric Cancer
Primary: a) Number of Participants With High Pain Levels (Using the Visual Analog Scale) — 31; 3 Participants
Phase 3 N=730 A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections
Type 2 Diabetes · Type 2 Diabetes Treated With Insulin
Primary: Change From Baseline in Hemoglobin A1c (HbA1c) [Noninferiority] — -1.01; -1.00 Percentage of HbA1c
N/A N=36 Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African Americans Study (GENE-FORECAST): Sodium Intervention Trial (SIT)
Cardiovascular Disease
Primary: Mean Change in Vascular Function Measured by Pulse Wave Velocity — 7.08; 7.13; 7.34; 7.07 m/s — p=0.98